Immune‐Responsive Bioinks Enable Vision‐Guided in Situ Robotic Bioprinting to Accelerate Diabetic Wound Healing
An immunomodulatory colloidal bioink that integrates zein‐based oxygen‐generating microparticles and human mesenchymal stem cells within a porous, mechanically robust matrix for adaptive in situ bioprinting for chronic diabetic wounds with clinical translational potential and broad future applicability is reported.